Breast imaging technologies are utilized to examine breast tissues in women for the detection of breast cancer and other breast-related disorders. According to Marketstack, the Global Breast Imaging Market is expected to grow considerably during the forecasted period. Factors such as breast imaging aid in the detection of breast cancer and other related problems as the multiple cases of breast cancer rise, which is expected to drive the Breast Imaging Market in the forecasted period. Further, the increasing number of government initiatives to spread awareness among people about the early diagnosis of breast cancer is expected to drive the Breast Imaging Market in the forecasted period. Furthermore, with the increased technological breakthroughs in breast imaging, the need for this technology is expected to drive the Breast Imaging Market in the forecasted period. However, the high cost associated with imaging systems or technology will obstruct market growth. Also, unfavourable reimbursement scenario in developing and underdeveloped economies is expected to restrain the Breast Imaging Market in the forecast period.

Mammography holds a significant segment in the Breast Imaging market. The mammography fragment of the global breast imaging market is growing due to the many initiatives taken for the early diagnosis of breast cancer. Breast imaging is a sub-specialty of radiology that consists of imaging of the breasts for screening or detection purposes. There are several methods of breast imaging using multiple technologies, like traditional screening and diagnostic mammography, xeromammography, breast tomosynthesis, galactography, breast MRI, breast ultrasound, and scintimammography. Conventional mammography uses X-ray technology, while breast tomosynthesis uses digital X-ray technology. Breast ultrasound can help differentiate between fluid-filled and solid lesions, while breast MRI is reserved for high-risk patients recently diagnosed with breast cancer. Scintimammography is utilized for patients with abnormal mammograms or whose screening is unreliable. Nowadays, the medical imaging practice also requires breast interventional procedures of both diagnosis procedures to direct surgical excision and percutaneous biopsy to acquire tissue localization. Breast imaging is transitioning into a multimodality practice, incorporating ultrasound and MRI technologies with raised frequency. Many newer tests are being developed for molecular breast imaging, including breast tomosynthesis and 3D mammography, which are currently used in some centres. Other tests are still under research and will take time to commercialize. Patients increasingly opt for digital mammography systems that offer high detection rates compared to traditionally used analogue devices.

Additionally, various organizations and healthcare centres are conducting cancer recognition campaigns to educate individuals about breast health and diagnostic measures. In addition, several advancements have prevented over-diagnosis and provided better sensitivity to detect more minor carcinomas. These continuous advancements in this field are expected to augment the mammography segment of the global breast Imaging market.

North America dominated the breast imaging market and is expected to grow considerably during the forecasted period. The expansion in the adoption of highly advanced techniques and systems in breast imaging and the technological advancements in breast cancer diagnostics is expected to increase the market's growth in the Asia Pacific region. The high awareness among the population of the availability of innovative diagnostic techniques in breast imaging contributes to the region's high breast imaging market demand. Minimally invasive techniques, such as wire-localization procedures, image-guided biopsies, and vacuum-assisted breast biopsies, offer less invasive alternatives in contrast to traditional open surgical procedures. These procedures provide accurate targeting and sampling of breast lesions with minimum scarring and faster recovery times. The rising patient preference for minimally invasive processes has driven the need for ionizing breast imaging technology that supports these techniques. Breast imaging has undergone various technological advances, from direct-exposure film mammography, xeromammography, and screen-film mammography to full-field digital mammography and contemporary digital breast tomosynthesis. These organized screening and technological advances have enabled the shaping of the speciality of breast imaging. With the growth of breast magnetic resonance imaging and breast ultrasonography, both complimentary to mammography, high-risk subgroups of women's disease have emerged. The diagnostic imaging centres segment is anticipated to post the fastest revenue increase. Due to its affordability and convenience, consumers are choosing standalone diagnostic imaging centres more frequently, which is a factor in this market segment's growth. Advanced imaging technologies are available in diagnostic imaging center, which often provide specialist imaging services, including computed tomography (CT) scanning, MRI, and breast imaging. Also, the availability of same-day test results at diagnostic imaging clinics encourages patients to use them. Diagnostic imaging facilities also give patients a more private and pleasant environment, which adds to their appeal.

Throughout the projection period, the segment of ambulatory surgery centres is also anticipated to have considerable expansion. The rise in breast operations carried out in mobile surgical facilities, which have a variety of advantages, including lower prices, shorter hospital stays, and decreased risks of hospital-acquired infections, might contribute to the expansion of this market segment. Furthermore, ambulatory surgical facilities have cutting-edge breast imaging technology, allowing for precise diagnosis and treatment planning. Additionally, ambulatory surgery clinics frequently provide individualized care, encouraging patient adoption. The rise in the approval of such innovative technologies in the region is adding to the development of the breast imaging market in the forecasted period. Thus, the increasing necessity for breast imaging technology coupled with elevating investment in the health care department is known to fuel the global market growth in this region.

The market key players are GE Healthcare, Hologic Inc, Philips Healthcare, Gamma Medica, Inc., and Siemens Healthcare.

In January 2023, A distributor agreement was signed by Genetik and Seno Medical for the Imagio Opto-Acoustic/Ultrasound Breast Imaging System, which uses non-invasive OA/US technology to distinguish between malignant breast lesions and benign in real-time. The imaging technique is suggested for adult patients who are required to assess treatable breast abnormalities and those who do not. An AI decision-support tool is available to help radiologists change from ultrasound alone to OA/US imaging, which more accurately assigns SenoGram and malignancy likelihood.

Global Breast Imaging Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Breast Imaging Market by segmenting based on Technologies (Ionizing Breast Imaging Technologies, Non-Ionizing Breast Imaging Technologies), End-User (Hospitals, Diagnostic Imaging Centre, Others), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East & Africa). The report examines the market drivers and restraints and the impact of COVID-19 on market growth in detail. The study covers emerging market trends, development, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.